Skip to main content

Advertisement

Log in

Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Moon KC, Lim IS, Choi Y (2006) Idiopathic membranous nephropathy in children. Pediatr Nephrol 21:1707–1715

    Article  PubMed  Google Scholar 

  2. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923–924

    Article  CAS  PubMed  Google Scholar 

  3. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC (2008) Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 73:117–125

    Article  CAS  PubMed  Google Scholar 

  4. Cohen CD, Calvaresi N, Armelloni S, Schmid H, Henger A, Ott U, Rastaldi MP, Kretzler M (2005) CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 18:328–333

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianping Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, B., Huang, J. Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy. Pediatr Nephrol 26, 637–638 (2011). https://doi.org/10.1007/s00467-010-1671-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-010-1671-2

Keywords

Navigation